Series B · Biotech · Copenhagen, Denmark · Founded 2021 · 11–50 employees
EvodiaBio develops natural flavors using precision fermentation technology, specifically producing monoterpenes and volatile aroma molecules at commercial scale. The company has achieved remarkable progress from laboratory to industrial production in just three years, with their Yops technology platform creating sustainable alternatives to climate-vulnerable hops for the beer industry. They have secured €20 million in total funding across three rounds and achieved commercial validation with over 70 commercial brews globally. The company is profitable and positioned to expand into Asian markets while extending their sustainable biotechnology to additional industries.
No open roles listed right now.